82 related articles for article (PubMed ID: 83324)
1. Plasminogen activator synthesis by cultured human embryonic lung cells: characterization of the suppressive effect of corticosteroids.
Rifkin DB
J Cell Physiol; 1978 Dec; 97(3 Pt 2 Suppl 1):421-8. PubMed ID: 83324
[TBL] [Abstract][Full Text] [Related]
2. Studies on the control of plasminogen activator production by cultured human embryonic lung cells: requirements for inhibition by corticosteroids.
Rifkin DB; Crowe RM
J Cell Physiol; 1980 Dec; 105(3):417-22. PubMed ID: 7193216
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
Busso N; Belin D; Failly-Crépin C; Vassalli JD
Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid sensitivity of OVCA 433 human ovarian carcinoma cells: inhibition of plasminogen activators, cell growth, and morphological alterations.
Amin W; Karlan BY; Littlefield BA
Cancer Res; 1987 Nov; 47(22):6040-5. PubMed ID: 3117361
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
10. Heparin potentiates endothelial cell growth factor stimulation of plasminogen activator synthesis by diploid human lung fibroblasts.
Rappaport RS; Ronchetti-Blume M; Vogel RL; Hung PP
Thromb Haemost; 1988 Jun; 59(3):514-22. PubMed ID: 2460964
[TBL] [Abstract][Full Text] [Related]
11. Role of polyamines in the stimulation of synthesis and secretion of plasminogen activator from bovine aortic endothelial cells.
Kuo BS; Korner G; Dryjski M; Bjornsson TD
J Cell Physiol; 1988 Oct; 137(1):192-8. PubMed ID: 3139680
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
14. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
15. Production of plasminogen activator and inhibition of embryonic cell aggregation by cultured human normal and neoplastic cells.
Phan Thu A; Popovic M
Neoplasma; 1979; 26(6):663-75. PubMed ID: 575560
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic modification of human glioma and non-small cell lung carcinoma by glucocorticoids and other agents.
McLean JS; Frame MC; Freshney RI; Vaughan PF; Mackie AE; Singer I
Anticancer Res; 1986; 6(5):1101-6. PubMed ID: 2879508
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids inhibit plasminogen activator production by endothelial cells.
Laug WE
Thromb Haemost; 1983 Dec; 50(4):888-92. PubMed ID: 6420927
[TBL] [Abstract][Full Text] [Related]
18. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
19. Isolation of rat hepatoma cell variants selectively resistant to dexamethasone inhibition of plasminogen activator.
Seifert SC; Gelehrter TD
J Cell Physiol; 1979 Jun; 99(3):333-41. PubMed ID: 457795
[TBL] [Abstract][Full Text] [Related]
20. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
